A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system

D Dan Chen X Xia-wen Yang J Jing Fu D Deng-zheng Zhang G Guo-Qing Chen W Wei Cai W Wen-long Xie

Article Details

Volume / Issue Vol. 15, Issue 1
Published August 28, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

D

Dan Chen

X

Xia-wen Yang

J

Jing Fu

D

Deng-zheng Zhang

G

Guo-Qing Chen

W

Wei Cai

W

Wen-long Xie